Clinical Trial Update: Thalidomide Plus Dexamethasone as Maintenance Therapy for Multiple Myeloma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating maintenance therapy with thalidomide plus dexamethasone for multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Thalidomide (thalidomide)

Snippet

Sponsor: Grupo de Estudos Multicentricos em Onco-Hematologia | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED